The druggable genome: an update
Tóm tắt
Từ khóa
Tài liệu tham khảo
International Human Genome Sequencing Consortium, 2004, Finishing the euchromatic sequence of the human genome, Nature, 431, 931, 10.1038/nature03001
Hopkins, 2003, Target analysis: a priori assessment of druggability, Ernst Schering Res. Found. Workshop, 2003, 11
Orth, 2004, The promise of genomics to identify novel therapeutic targets, Expert Opin. Ther. Targets, 8, 587, 10.1517/14728222.8.6.587
Muller, 2003, Medicinal chemistry of target family-directed masterkeys, Drug Discov. Today, 8, 681, 10.1016/S1359-6446(03)02781-8
Drews, 1997, The role of innovation in drug development, Nat. Biotechnol., 15, 1318, 10.1038/nbt1297-1318
Drews, 2000, Drug discovery: a historical perspective, Science, 287, 1960, 10.1126/science.287.5460.1960
Mulder, 2005, InterPro, progress and status in 2005, Nucleic Acids Res., 33, D201, 10.1093/nar/gki106
Manning, 2002, The protein kinase complement of the human genome, Science, 298, 1912, 10.1126/science.1075762
Fredriksson, 2003, The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints, Mol. Pharmacol., 63, 1256, 10.1124/mol.63.6.1256
Puente, 2003, Human and mouse proteases: a comparative genomic approach, Nat. Rev. Genet., 4, 544, 10.1038/nrg1111
Messager, 2005, Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54, Proc. Natl. Acad. Sci. U. S. A., 102, 1761, 10.1073/pnas.0409330102
Seminara, 2003, The GPR54 gene as a regulator of puberty, N. Engl. J. Med., 349, 1614, 10.1056/NEJMoa035322
Roth, 2004, Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia, Nat. Rev. Drug Discov., 3, 353, 10.1038/nrd1346